A Tibetan medicine composition for treating stroke caused by phlegm and blood stasis blocking collaterals

A technology of phlegm and blood stasis blocking collaterals and composition, applied in the field of Tibetan medicine, can solve the problems of inconvenient preparation production, processing, and high content of medicinal flavor, and achieve the effects of remarkable curative effect, simple prescription and definite curative effect.

Active Publication Date: 2019-06-04
SHANDONG JINHE DRUG RES DEV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Zhenlong Xingnao Capsules are composed of 29 medicinal materials, which contain a lot of medicinal flavors, and there are many inconveniences in the production and processing of preparations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A Tibetan medicine composition for treating stroke caused by phlegm and blood stasis blocking collaterals
  • A Tibetan medicine composition for treating stroke caused by phlegm and blood stasis blocking collaterals
  • A Tibetan medicine composition for treating stroke caused by phlegm and blood stasis blocking collaterals

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0024] Experimental example. Effect experiment on neurological function recovery after cerebral ischemic injury

[0025] 1. Test material

[0026] 1.1 Sample

[0027] Prescription of the present invention (hereinafter referred to as new prescription): the formula of Example 1 of the present invention is mixed and pulverized together into fine powder, mixed evenly, and packaged to obtain a powder.

[0028] Zhenlong Xingnao Capsule, specification 0.3g / capsule, batch number: 20130701, Jinhe Tibetan Medicine Co., Ltd.

[0029] Naoxintong Capsules, specification 0.4g / capsule, batch number: 130642, Shaanxi Buchang Pharmaceutical Co., Ltd.

[0030] 1.2 Experimental animals and grouping

[0031] SD rats, male, weighing 270-300 g, Experimental Animal Center, Shandong Natural Medicine Engineering Technology Research Center,

[0032] Certificate number: SCXK (Lu) 20090009.

[0033] 1.3 Instruments and reagents

[0034] MCAO thread, Beijing Shadong Biotechnology Co., Ltd., product n...

Embodiment 1

[0084] Embodiment 1 A kind of Tibetan medicine composition for the treatment of apoplexy, the crude drug consists of:

[0085] 150g of artificial bezoar, 150g of geranium, 75g of pearl, 25g of saffron, 25g of artificial musk, 75g of jujube, 75g of Viola, 50g of grass fruit, and 75g of myrobalan.

[0086] It is prepared by directly mixing and pulverizing the above raw materials.

Embodiment 2

[0087] Embodiment 2 A kind of Tibetan medicine composition for the treatment of apoplexy, the crude drug consists of:

[0088] 120g of artificial bezoar, 120g of geranium, 75g of pearl, 25g of saffron, 20g of artificial musk, 60g of jujube, 60g of Viola 60g, 50g of grass fruit, and 70g of myrobalan.

[0089] Jujube, Corydalis, Tsaoguo, and Myrobalan in the above raw materials are extracted, refined, and dried by conventional methods of traditional Chinese medicine preparations, and then mixed with artificial bezoar, Tianzhuhuang, pearl, saffron, and artificial musk. .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a Tibetan medicine composition for treating stroke caused by stagnation of phlegm and blood. The composition is obtained by reducing on the basis of the prescription of an original Zhenlongxingnao capsule, exactly 29 medicines in the original Zhenlongxingnao capsule prescription is reduced to 9 medicines. Based upon animal tests, the composition disclosed by the invention is concrete in curative effect, and the composition is capable of effectively treating the stroke caused by stagnation of phlegm and blood and promoting angiogenesis and nerve regeneration of experimental rats; and compared with the original Zhenlongxingnao capsule, the Tibetan medicine composition can avoid a significant difference in curative effect.

Description

technical field [0001] The invention relates to a Tibetan medicine composition for treating apoplexy, in particular to a Tibetan medicine composition for treating apoplexy caused by obstruction of collaterals by phlegm and blood stasis, and belongs to the field of Tibetan medicine. Background technique [0002] Stroke, also known as cerebral apoplexy, is an acute local cerebrovascular disease characterized by high morbidity, high disability, and high mortality, which seriously endangers the physical and mental health of middle-aged and elderly people. Phlegm and blood stasis obstructing collaterals is an important pathogenesis of ischemic stroke. This is the consensus of all scholars. A large number of clinical observations and studies have also confirmed that phlegm and blood stasis block each other. Loss of nourishment, hair is apoplexy, phlegm stasis and numbness run through apoplexy all the time. However, until today, stroke is still a major clinical disease that plague...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9064A61P9/10A61K35/618A61K35/55A61K35/413
Inventor 姬涛李怀平王海苹孙绪丁王朔
Owner SHANDONG JINHE DRUG RES DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap